Bovie Medical retools outlook

Bovie Medical (NYSE:BVX), fresh from the sale of its core electro-cautery business, saw its share price take a hit today after it updated its outlook for the rest of the year.
Last month Bovie dealt its core business, including the Bovie brand, to Symmetry Surgical for $97 million. The all-cash sale augured a pivot for Clearwater, Fla.-based Bovie toward the cosmetic surgery market with its J-Plasma and Renuvion brands.
Today Bovie said it expects to post net losses of -$12.7 million to -$12.3 million on sales of $15.2 million to $15.6 million.
The news sent BVX shares down -5.4% to $5.85 apiece today in pre-market trading.
The post Bovie Medical retools outlook appeared first on MassDevice.

Source: Mass Device - September 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cosmetic/Aesthetic Wall Street Beat Bovie Medical Corp. Source Type: news